MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
48.19
+0.14 (0.29%)
Oct 29, 2024, 4:00 PM EDT - Market closed
MLTX Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 |
Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 342.79 | 451.17 | 39.51 | 8.04 |
Short-Term Investments | 177.01 | 59.84 | 32.61 | - |
Cash & Short-Term Investments | 519.8 | 511.01 | 72.11 | 8.04 |
Cash Growth | 3.59% | 608.60% | 797.08% | - |
Other Receivables | 1.68 | 1.06 | 0.22 | 0.15 |
Receivables | 1.68 | 1.06 | 0.22 | 0.15 |
Prepaid Expenses | 15.41 | 2.1 | 4.18 | 1.45 |
Total Current Assets | 536.88 | 514.17 | 76.51 | 9.64 |
Property, Plant & Equipment | 3.87 | 3.95 | 0.33 | 0.05 |
Other Long-Term Assets | 4.13 | 8.42 | - | - |
Accounts Payable | 0.18 | 0.26 | 0.16 | 0.03 |
Accrued Expenses | 9.95 | 8.14 | 7.24 | 4.76 |
Short-Term Debt | - | - | - | 15 |
Current Portion of Leases | 1.32 | 1.2 | 0.15 | - |
Current Income Taxes Payable | 0.62 | 0.37 | 0.11 | 0.06 |
Other Current Liabilities | 0.21 | - | - | 1.23 |
Total Current Liabilities | 12.28 | 9.97 | 7.67 | 21.09 |
Long-Term Leases | 2.02 | 2.5 | 0.13 | - |
Common Stock | 0.01 | 0.01 | 0.01 | 0.04 |
Additional Paid-In Capital | 672 | 609.97 | 129.19 | 42.06 |
Retained Earnings | -154.6 | -116.66 | -80.65 | -53.64 |
Treasury Stock | - | - | - | -0.01 |
Comprehensive Income & Other | 3.26 | 2.36 | 0.35 | -0.17 |
Total Common Equity | 520.66 | 495.68 | 48.9 | -11.72 |
Minority Interest | 9.37 | 17.82 | 19.87 | - |
Total Liabilities & Equity | 544.88 | 526.54 | 76.84 | 9.68 |
Total Debt | 3.34 | 3.7 | 0.28 | 15 |
Net Cash (Debt) | 516.46 | 507.31 | 71.83 | -6.96 |
Net Cash Growth | 2.97% | 606.24% | - | - |
Net Cash Per Share | 8.64 | 10.33 | 2.45 | -0.89 |
Filing Date Shares Outstanding | 62.89 | 62.87 | 39.15 | 0.3 |
Total Common Shares Outstanding | 62.87 | 60.47 | 38.98 | 0.3 |
Working Capital | 524.6 | 504.2 | 68.85 | -11.45 |
Book Value Per Share | 8.28 | 8.20 | 1.25 | -38.57 |
Tangible Book Value | 520.66 | 495.68 | 48.9 | -11.72 |
Tangible Book Value Per Share | 8.28 | 8.20 | 1.25 | -38.57 |
Source: S&P Capital IQ. Standard template.
Financial Sources.